Salvage thoracoscopic resection after nivolumab for stage IV

Date, Hiroshi

Salvage thoracoscopic resection after nivolumab for stage IV

Posted on 2020-04-12 - 12:06

There are limited data on the surgical management of localized and residual diseases in patients with stage IV non-small-cell lung cancer that was treated with nivolumab. Herein, we present two patients who underwent salvage thoracoscopic resection for residual diseases (left lower lobectomy and paratracheal lymph node resection, respectively) after chemotherapy and immunotherapy for stage IV adenocarcinoma. The indications, intraoperative findings, and histopathological findings are discussed in this report.

CITE THIS COLLECTION

DataCite

3 Biotech

3D Printing in Medicine

3D Research

3D-Printed Materials and Systems

4OR

AAPG Bulletin

AAPS Open

AAPS PharmSciTech

Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg

ABI Technik (German)

Academic Medicine

Academic Pediatrics

Academic Psychiatry

Academic Questions

Academy of Management Discoveries

Academy of Management Journal

Academy of Management Learning and Education

Academy of Management Perspectives

Academy of Management Proceedings

Academy of Management Review

Hamaji, Masatsugu; Ozasa, Hiroaki; Yoshizawa, Akihiko; Date, Hiroshi (2020). Salvage thoracoscopic resection after nivolumab for stage IV. SAGE Journals. Collection. https://doi.org/10.25384/SAGE.c.4934574.v1

https://doi.org/10.25384/SAGE.c.4934574.v1

or

Select your citation style and then place your mouse over the citation text to select it.